Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Multiple traits more common in difficult-to-treat patients with migraine

Publish date:: August 13, 2020

Key clinical point: Patients who respond insufficiently to migraine treatment are more medically complex.

Major finding: Compared with patients who respond well to treatment, they are more likely to have four or more migraine headache days per month (46% vs. 31%), rebound or medication-overuse headaches (16% vs. 7%) and chronic migraine (12% vs. 5%, all P < .05).

Study details: Retrospective analysis of 2014 cross-sectional survey data (583 patients with migraine; 34% defined as insufficient responders).

Disclosures: No study funding was reported. Four study authors reported ties with Eli Lilly, and two reported employment by Adelphi Real World, which provided the survey results.

Citation:

Lombard L et al. Headache. 2020;60(7):1325-39. doi: 10.1111/head.13835.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Headache & Migraine

HIT-6 may help track meaningful change in chronic migraine,

Choroid plexuses may play a role in migraine,

Multiple traits more common in difficult-to-treat patients with migraine,

Marijuana for migraine? Some tentative evidence,

Low vitamin D levels in patients with migraine,